Daiwa Securities Group Inc. Verona Pharma PLC Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
A detailed history of Daiwa Securities Group Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 244 shares of VRNA stock, worth $10,413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244
Previous 244
-0.0%
Holding current value
$10,413
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$270 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$238 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$214 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$180 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$152 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.6B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...